Health Canada has announced a recall of over 17,000 cannabis products due to serious labeling inaccuracies which could have led to unintended intoxication. The recall affects various items, including softgels and oil extracts, distributed across six provinces and the Yukon from December 2022 to July 2024.
The products involved in the recall include Emprise CBN+CBD 50 mg softgels, NuLeaf Naturals 1800 mg full-spectrum hemp multicannabinoid oil and softgels, and Ultra Plus 1200 mg and 750 mg multicannabinoid oils and softgels. These items were labeled as containing less than 3 milligrams of intoxicating cannabinoids—hexahydrocannabinol (HHC) and tetrahydrocannabinol (THC)—per unit. However, inspections revealed that the actual levels of these cannabinoids were significantly higher than stated.
Consumers have reported adverse effects, with two reports to iNaturally Organic Inc. and five to Health Canada, along with one additional complaint. Health Canada is urging anyone with these products to stop using them immediately and either return or properly dispose of them.
Ingesting THC and HHC can lead to cannabis poisoning, which may manifest as chest pain, rapid heartbeat, nausea, vomiting, psychotic episodes, respiratory issues, severe anxiety, and panic attacks. Severe cases may necessitate hospitalization.
Following inspections, Health Canada confirmed that the recalled products contained dangerously high levels of THC and HHC. This mislabeling undermines consumers' ability to make informed choices regarding their cannabis use.
Consumers who have these products are advised to return or dispose of them as soon as possible and seek medical advice if they experience any adverse effects.
For more information on the recalls from Health Canada visit: